Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$518.81 - $607.81 $231,389 - $271,083
446 New
446 $260,000
Q4 2023

Jan 23, 2024

BUY
$437.42 - $470.64 $276,449 - $297,444
632 New
632 $292,000
Q2 2023

Jul 25, 2023

SELL
$354.01 - $427.31 $20,178 - $24,356
-57 Reduced 7.41%
712 $304,000
Q1 2023

Apr 20, 2023

BUY
$335.35 - $386.06 $5,365 - $6,176
16 Added 2.12%
769 $273,000
Q4 2022

Jan 25, 2023

BUY
$346.68 - $397.58 $261,050 - $299,377
753 New
753 $0
Q2 2022

Jul 18, 2022

SELL
$300.57 - $336.42 $191,463 - $214,299
-637 Reduced 36.11%
1,127 $368,000
Q1 2022

Apr 20, 2022

SELL
$244.61 - $310.48 $144,809 - $183,804
-592 Reduced 25.13%
1,764 $540,000
Q4 2021

Jan 04, 2022

BUY
$198.21 - $248.9 $30,722 - $38,579
155 Added 7.04%
2,356 $586,000
Q3 2021

Nov 04, 2021

BUY
$188.42 - $208.66 $414,712 - $459,260
2,201 New
2,201 $439,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $82.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Camelot Portfolios, LLC Portfolio

Follow Camelot Portfolios, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camelot Portfolios, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camelot Portfolios, LLC with notifications on news.